Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
about
High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerDigital gene expression approach over multiple RNA-Seq data sets to detect neoblast transcriptional changes in Schmidtea mediterranea.A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivoBase excision repair: a critical player in many gamesCellular senescence and protein degradation: breaking down cancerTransforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cellsInfinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.NF-Y Binding Site Architecture Defines a C-Fos Targeted Promoter ClassmRNA and DNA selection via protein multimerization: YB-1 as a case study.Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.Genome- wide characterization of Nuclear Factor Y (NF-Y) gene family of sorghum [Sorghum bicolor (L.) Moench]: a bioinformatics approachA polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibilityAstrocyte-mediated regulation of multidrug resistance p-glycoprotein in fetal and neonatal brain endothelial cells: age-dependent effects.Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.Treatment of obstructive sleep apnea alters cancer-associated transcriptional signatures in circulating leukocytes.YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancerNuclear transcription factor Y and its roles in cellular processes related to human disease.YB-1 protein: functions and regulation.NF-Y activates genes of metabolic pathways altered in cancer cells.Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.A high definition look at the NF-Y regulome reveals genome-wide associations with selected transcription factors.YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice.Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.Expanding the map of protein-RNA interaction sites via cell fusion followed by PAR-CLIP.CONSTANS Imparts DNA Sequence Specificity to the Histone Fold NF-YB/NF-YC Dimer.The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors.Epigenetic signature of preterm birth in adult twins.The Role of YB1 in Renal Cell Carcinoma Cell AdhesionThe animal nuclear factor Y: an enigmatic and important heterotrimeric transcription factor
P2860
Q26774902-CDBFEFC8-4131-408E-8E2A-5793A291E78FQ30946349-D0552C5C-6486-4292-93A4-B4384D1B9277Q33785593-F02B2AE5-4F44-4782-B5E8-463C69646849Q33908163-CC35F267-8D54-42BB-8FE2-6895F524EC8CQ33953067-7987C24A-5BB1-4CD8-B54C-541AAC2C9F0CQ34355665-14FDA1D7-0DDE-4B81-9677-F447127866F0Q35990914-2C6E2077-7A4E-4F40-9FAD-737822209C70Q36102690-DEDD93B6-D73D-4645-B26D-BDFCABAEF0BBQ36228025-E44A1ED8-B8BE-4CBA-AC7F-62FC0E76BF36Q36546008-E5D7D259-8853-4508-A73C-37854A3FF7DAQ36823495-A0D27B02-94F7-480F-A22A-581BC4A8E5E8Q37151432-24743257-F5CB-4B3F-B571-15AD1DF31C45Q37212822-B0733834-6EDE-4DCC-9C2F-6E73A3DB9334Q37451300-439CAD12-4CC3-4F8E-85B5-98E9C4864243Q37637184-A8876739-5D1E-495E-A416-C8564D333AC2Q37696095-ACF46711-7977-4DB2-A580-784F038356B2Q37702641-3D537359-EA71-4F17-858F-4B9C61ABE439Q38131490-706BBFF2-A011-45F7-B753-829BF92299FCQ38161834-CEED829F-31F0-469C-B7FF-E0F14C3778A0Q38294889-40CC3129-0A7F-48F0-B189-D335A8D6891CQ38673660-C3C9C1E9-AECB-4A59-8245-000CF51EA029Q38792432-F57881B7-17A4-43E3-89E4-83BF2C2F8749Q38806933-109835F4-6E00-47A3-84C5-BB22EA1091F1Q38950645-12EAF279-991A-4E7D-8ECC-875BEB0E5296Q41335354-E7F63DC4-32BA-4DE2-BB7D-8477BA56575BQ41396285-03F54CFD-E489-4406-8E9A-3C2BFB6250E0Q42806236-6CC0BEAB-4A7B-4751-98C5-51BFE19A5488Q47657839-FBB290BE-C15C-4CDF-9811-25A7C6194FD3Q48119881-493553C5-443D-403E-9139-3AF142A69DF7Q54935812-BF315A69-238E-4D1E-8E3E-609E6D7FDD3FQ55513060-5BF49EBE-6C60-41AE-B42B-EBBF4F03C824Q57135008-EFD979BF-F886-475C-B00C-EE8D54CCC7E9Q57177538-989E33B0-C434-47CE-AED5-960FCEF16A74
P2860
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@ast
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@en
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@nl
type
label
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@ast
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@en
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@nl
prefLabel
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@ast
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@en
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@nl
P2860
P3181
P356
P1476
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?
@en
P2093
R Mantovani
P2860
P2888
P304
P3181
P356
10.1038/CDD.2013.13
P407
P577
2013-03-01T00:00:00Z
P5875
P6179
1033865840